VANDERBILT UNIVERSITY MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vumc.org
A Study Comparing Vaginal Misoprostol and Intravenous Oxytocin for Induction of Labor
Not Applicable
Completed
- Conditions
- Induction of Labor in Multiparous Women
- Interventions
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2017-12-19
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 130
- Registration Number
- NCT01634854
Exhaled NO Testing in Filariasis
Completed
- Conditions
- Filariasis
- First Posted Date
- 2012-06-26
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 96
- Registration Number
- NCT01628497
- Locations
- 🇬🇾
Georgetown Public Hospital Corporation, Georgetown, Region 4, Guyana
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 7
- Registration Number
- NCT01625455
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
A Clinical Trial of A Pacifier-Activated Music Player
Not Applicable
Completed
- Conditions
- Prematurity
- Interventions
- Device: Pacifier-Activated-Lullaby system (PAL).
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01600586
- Locations
- 🇺🇸
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States
Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema
Phase 4
Terminated
- Conditions
- ACE Inhibitor-associated Angioedema
- Interventions
- Other: Placebo
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT01574248
- Locations
- 🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Comparative Effectiveness and Cost-Benefit Analysis of Vancomycin Powder in High Risk Spine Surgery Patients
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Vanderbilt University Medical Center
- Registration Number
- NCT01566422
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population
Not Applicable
Terminated
- Conditions
- Identify Normal MII-pH Parameters
- Interventions
- Procedure: 24-hr pH monitoring
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT01566383
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome
Not Applicable
Completed
- Conditions
- Postural Orthostatic Tachycardia Syndrome
- Interventions
- Radiation: Plasma VolumeProcedure: Exercise Capacity Test - BicycleProcedure: Posture Study
- First Posted Date
- 2012-03-26
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 38
- Registration Number
- NCT01563107
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Effect of Dietary Sodium Intake on Vascular Endothelium
Not Applicable
Completed
- Conditions
- Postural Tachycardia Syndrome (POTS)
- Interventions
- Procedure: Pulsitile Arterial Tonometry (PAT) ProtocolDevice: Calf Blood Flow in Reactive Hyperemia (CBF-RH)Device: Evaluation of Forearm-Mediated Dilation
- First Posted Date
- 2012-03-09
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT01550315
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Phase 2
Completed
- Conditions
- Dystrophic Epidermolysis Bullosa
- Interventions
- Drug: Granulocyte Colony Stimulating Factor (GCSF)
- First Posted Date
- 2012-02-24
- Last Posted Date
- 2017-06-23
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 7
- Registration Number
- NCT01538862
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath